Equity Alert – The M&A Class Action Firm Announces the Investigation of La Jolla Pharmaceutical Co. – LJPC
NEW YORK, July 16, 2022 /PRNewswire/ — Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating La Jolla Pharmaceutical Co. (LJPC), relating to its proposed acquisition by Innovia, Inc. Under the terms of the agreement, LJPC shareholders are expected to receive $6.23 in cash per share they own. Click here for more information: http://monteverdelaw.com/case/la-jolla-pharmaceutical-co. It is free and there is no cost or obligation to you.
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale
If you own common stock in LJPC and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (212) 971-1341.
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
Tel: (212) 971-1341
Attorney Advertising. (C) 2022 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
View original content to download multimedia:https://www.prnewswire.com/news-releases/equity-alert—the-ma-class-action-firm-announces-the-investigation-of-la-jolla-pharmaceutical-co—ljpc-301587715.html
SOURCE Monteverde & Associates PC
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.